PAMELA WHEAT: Open Payments
NPI 1952408262 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 41 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $1,056
Food & beverage: $917Education: $139
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $211 |
| Teva Pharmaceuticals USA, Inc. | 6 | $178 |
| Axsome Therapeutics, Inc. | 5 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $131 |
| Neurocrine BioSciences, Inc. | 3 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Lundbeck LLC | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
Products named: Jornay PM, Auvelity, CAPLYTA, INGREZZA, REXULTI, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across MO — which companies pay providers there.
